Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Dougherty

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1986
T lymphocyte-dependent evolution of bacterial cell wall-induced hepatic granulomasS M Wahl, J B Allen, S Dougherty, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2001
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patientsE Fisher, R A Rudick, G Cutter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1988
Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferationS M Wahl, D A Hunt, H L Wong, et al.
Journal of Protein Chemistry|February 24, 2001
Steady-state kinetic analysis of human ubiquitin-activating enzyme (E1) using a fluorescently labeled ubiquitin substrateK E Wee, Z Lai, K R Auger, et al.
Neurology|November 13, 2002
Eight-year follow-up study of brain atrophy in patients with MSE Fisher, R A Rudick, J H Simon, et al.
AIDS Care|January 14, 2021
Impact and correlates of sub-optimal social support among patients in HIV careR J Fredericksen, L E Gibbons, E Fitzsimmons, et al.
AIDS Care|March 13, 2023
Vaporized nicotine use among patients in HIV care who smoke tobacco: perceived health effects and effectiveness as a smoking cessation toolR J Fredericksen, E Fitzsimmons, L N Drumright, et al.
Nature Communications|February 5, 2026
A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responsesAbigail E Powell, Hannah Caruso, Soyoon Park, et al.
Neurology|August 1, 1997
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)R A Rudick, D E Goodkin, L D Jacobs, et al.
Annals of Neurology|March 1, 1996
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)L D Jacobs, D L Cookfair, R A Rudick, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1986
T lymphocyte-dependent evolution of bacterial cell wall-induced hepatic granulomasS M Wahl, J B Allen, S Dougherty, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 24, 2001
Relationship between brain atrophy and disability: an 8-year follow-up study of multiple sclerosis patientsE Fisher, R A Rudick, G Cutter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1988
Transforming growth factor-beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferationS M Wahl, D A Hunt, H L Wong, et al.
Journal of Protein Chemistry|February 24, 2001
Steady-state kinetic analysis of human ubiquitin-activating enzyme (E1) using a fluorescently labeled ubiquitin substrateK E Wee, Z Lai, K R Auger, et al.
Neurology|November 13, 2002
Eight-year follow-up study of brain atrophy in patients with MSE Fisher, R A Rudick, J H Simon, et al.
AIDS Care|January 14, 2021
Impact and correlates of sub-optimal social support among patients in HIV careR J Fredericksen, L E Gibbons, E Fitzsimmons, et al.
AIDS Care|March 13, 2023
Vaporized nicotine use among patients in HIV care who smoke tobacco: perceived health effects and effectiveness as a smoking cessation toolR J Fredericksen, E Fitzsimmons, L N Drumright, et al.
Nature Communications|February 5, 2026
A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responsesAbigail E Powell, Hannah Caruso, Soyoon Park, et al.
Neurology|August 1, 1997
Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)R A Rudick, D E Goodkin, L D Jacobs, et al.
Annals of Neurology|March 1, 1996
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)L D Jacobs, D L Cookfair, R A Rudick, et al.
Pageof 7